FTSE 100 today: Edges higher as pound slips; Mitchells & Butlers jumps on results
Investing.com - BMO Capital raised its price target on Assurant (NYSE:AIZ) to $246.00 from $238.00 on Monday, while maintaining an Outperform rating on the stock. The new target represents a potential 10% upside from Assurant ’s current price of $224.32, with InvestingPro data showing the stock is trading near its 52-week high of $230.55.
The firm revised its 2025 earnings per share estimates upward by 9%, while keeping 2026 and 2027 estimates unchanged. This adjustment primarily reflects Assurant’s third-quarter earnings beat and stronger growth projections in its Lifestyle segment. According to InvestingPro data, Assurant is trading at a P/E ratio of 13.67 with a favorable PEG ratio of 0.77, indicating the stock is attractively valued relative to its growth potential.
BMO Capital noted that the stronger growth outlook in the Lifestyle segment stems from two recently announced new business wins by Assurant, though specific details about these wins were not provided.
The firm acknowledged that much of Assurant’s third-quarter earnings beat was driven by factors that may not continue, including lower catastrophe losses, reserve releases, and a one-time increase in the Auto segment.
Despite these non-recurring factors, BMO Capital indicated that the strong quarter should enhance market confidence in the near-term strength of Assurant’s business pipeline.
In other recent news, Assurant Inc. reported impressive financial results for the third quarter of 2025. The company achieved an earnings per share (EPS) of $5.76, significantly beating analysts’ projections of $4.32, resulting in a 33.33% positive surprise. Assurant also surpassed revenue expectations, bringing in $3.23 billion compared to the anticipated $3.16 billion. These results highlight the company’s strong performance in the recent quarter. Additionally, the company’s stock saw an increase in premarket trading. Analysts’ reactions to Assurant’s earnings report were notably positive, reflecting confidence in the company’s financial health. The firm’s ability to exceed both earnings and revenue forecasts has been a focal point in recent discussions among investors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.